| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 68,419 | 61,390 | 59,360 | 59,647 | | Cost of Revenue | 49,816 | 47,313 | 48,737 | 45,219 | | | Gross Profit | 18,603 | 14,077 | 10,623 | 14,428 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,923 | 11,305 | 12,081 | 13,076 | | Non Recurring |
-
|
-
| 15,607 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,680 | 2,772 | (17,065) | 1,352 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 8,004 | 2,772 | (17,065) | 1,352 | | Interest Expense | (574) | 153 | 194 | 227 | | Income Before Tax | 8,578 | 2,619 | (17,259) | 1,125 | | Income Tax Expense | 2,861 | 1,007 | (6,086) | 422 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,717 | 1,612 | (11,173) | 703 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,717 | 1,612 | (11,173) | 703 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,717 | $1,612 | ($11,173) | $703 |
|
0.51% Nasdaq 
Income Statement
